Engagement of the OX-40 receptor in vivo enhances antitumor immunity.

MLA

Weinberg, A. D., et al. “Engagement of the OX-40 Receptor in Vivo Enhances Antitumor Immunity.” Journal of Immunology (Baltimore, Md. : 1950), vol. 164, no. 4, Feb. 2000, pp. 2160–69. EBSCOhost, https://doi.org/10.4049/jimmunol.164.4.2160.

APA

Weinberg, A. D., Rivera, M. M., Prell, R., Morris, A., Ramstad, T., Vetto, J. T., Urba, W. J., Alvord, G., Bunce, C., & Shields, J. (2000). Engagement of the OX-40 receptor in vivo enhances antitumor immunity. Journal of Immunology (Baltimore, Md. : 1950), 164(4), 2160–2169. https://doi.org/10.4049/jimmunol.164.4.2160

Chicago

Weinberg, A D, M M Rivera, R Prell, A Morris, T Ramstad, J T Vetto, W J Urba, G Alvord, C Bunce, and J Shields. 2000. “Engagement of the OX-40 Receptor in Vivo Enhances Antitumor Immunity.” Journal of Immunology (Baltimore, Md. : 1950) 164 (4): 2160–69. doi:10.4049/jimmunol.164.4.2160.